Pharma Focus Asia

Eli Lilly and Company Plans to Open New Manufacturing Facility in Indiana

Eli Lilly and Company Invests US$$2.1 billion for the construction of new manufactruing facility. The two new manufacturing sites will be located at Indiana's LEAP Lebanon Innovation and the other at Research District in Boone County.

The new facility will widen the manufacturing network for active ingredients and new therapeutic modalities, such as genetic medicines, to strengthen its portfolio in potentially life-changing treatments.

With the addition of this new capacity, will support the increasing pipeline of innovative medicines.  The new project is estimated to create an additional 500 high tech new job roles benefitting Hoosiers.


NameEli Lilly and Company
TypeNew Construction
BudgetUS$2.1 billion
magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference